Clinical Trials in San Francisco

Showing 7681-7700 of 12,991 trials

Vaccine Study for Surgically Resected Pancreatic Cancer

NCT00569387

To assess the response for subjects with pancreatic cancer that have undergone surgical resection and treatment with a vaccine given with chemotherapy and chemoradiation.

Pancreatic Cancer

NewLink Genetics Corporation73 participantsStarted Dec 2007

Scottsdale, Arizona, United States • Los Angeles, California, United States • Orange, California, United States +15 more locations

COMPLETED< 1 mile

Transvenous Lead Removal Post-Market Clinical Study

NCT03688412

This prospective, multicenter, post-market clinical study was designed to evaluate the outcomes of lead extraction of cardiovascular implantable electronic devices (CIED) using Cook catheter and lead extraction devices for any indication it is used in the commercial setting within the United States and Europe. The purpose of this clinical study is to collect data on the performance of the Cook lead extraction devices for the purpose of supporting publications and presentations

Cardiac Electrophysiology

Cook Research Incorporated230 participantsStarted Oct 2018

San Francisco, California, United States • Urbana, Illinois, United States • Raleigh, North Carolina, United States +6 more locations

Vaccine Study for Surgically Resected Pancreatic Cancer

Transvenous Lead Removal Post-Market Clinical Study

Find Trials by Condition in San Francisco

Immunotherapy Study for Surgically Resected Pancreatic Cancer

Multimodal Sleep Pathway for Shoulder Arthroplasty

A Study of Ocrelizumab in Participants With Relapsing Remitting Multiple Sclerosis (RRMS) Who Have Had a Suboptimal Response to an Adequate Course of Disease-Modifying Treatment (DMT)

NFAT-Dependent Cytokine Gene Expression for Immune Monitoring in Kidney Transplant Patients

ICON1: Treatment Decisions and Outcomes in Pediatric Refractory ITP

Dupilumab As An Adjunct For Subcutaneous Grass Immunotherapy

Pyruvate Kinase Deficiency Natural History Study

Adult Study: ABT-414 Alone or ABT-414 Plus Temozolomide vs. Lomustine or Temozolomide for Recurrent Glioblastoma Pediatric Study: Evaluation of ABT-414 in Children With High Grade Gliomas

Selinexor in Combination With Fludarabine and Cytarabine in Patients With Refractory or Relapsed Acute Myeloid Leukemia

Choice of Modality of Follow up for Medication Abortion

Study of Dupilumab (REGN668/SAR231893) Monotherapy Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis

A Study to Evaluate the Safety and Clinical Study of Azelaic Acid Gel 15% in Patients With Moderate Facial Rosacea

Immunotherapy Study in Progressive or Relapsed Non-Small Cell Lung Cancer

A Phase 1b Open Label, Dose Escalation Study of PLX3397 in Combination With Vemurafenib in V600-mutated BRAF Melanoma

CRLX101(NLG207) in Combination With Bevacizumab for Metastatic Renal Cell Carcinoma (mRCC) Versus Standard of Care (SOC)

Andecaliximab With mFOLFOX6 as First Line Treatment for Advanced Gastric or Gastroesophageal Junction Adenocarcinoma

A Phase 3 Substudy to Evaluate Executive Function in Adults With PKU Who Are Participating in the Phase 3 Study, 165-302

Pharmacokinetics of Anti-epileptic Drugs in Obese Children